3-bromo-6-ethoxy-1,4-dihydroquinolin-4-one, 97%, 1g

2-(Sec-butyl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one, 97%, 5g

2-{[(tert-butoxy)carbonyl](cyclopropyl)amino}propanoic acid, 95+%, 250mg

3-Oxo-3-o-tolyl-propionic acid methyl ester, 95.0%, 500mg

2-(Piperazin-1-yl)pyrazine hydrochloride, 95%, 2.5g

Glicole propilenico monoetil etere, min 99%, per sintesi, 2,5 l, confezione in plastica.

(2-METHYL-1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)BORONIC ACID PINACOL ESTER, 95.0%, 1g

tert-Butyl 5-bromo-1H-benzo[d]imidazole-1-carboxylate, 97%, 1g

3-Ethyl-2-pyrrolidinone, 95.0%, 1g

1-(2-thienyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine, 95.0%, 500mg

8-hydroxy-1,2-dihydroisoquinolin-1-one, 97%, 100mg

5-Bromo-2-hydroxynicotinic Acid>98.0%(GC)(T)5g

N-(3,3-difluorocyclobutyl)formamide, 98%, 100mg